CM
EXAS

Castleark Management’s Exact Sciences EXAS Stock Holding History

Castleark Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-19,995
Closed -$1.81M – 361
2019
Q3 		$1.81M Hold
19,995
– – 0.07% 213
2019
Q2 		$2.36M Sell
19,995
-10,755
-35% -$1.08M 0.09% 206
2019
Q1 		$2.66M Buy
30,750
+5,810
+23% +$495K 0.1% 201
2018
Q4 		$1.57M Sell
24,940
-6,800
-21% -$467K 0.07% 241
2018
Q3 		$2.5M Buy
+31,740
New +$2.07M 0.07% 241
2015
Q1 		– Sell
-205,081
Closed -$5.63M – 364
2014
Q4 		$5.63M Buy
+205,081
New +$4.99M 0.15% 161

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Castleark Management's EXAS Position: Q4 2019 in Review

Castleark Management sold out of Exact Sciences (EXAS) in Q4 2019, closing a stake of 19,995 shares — an estimated $1.81M sold.

Castleark Management first reported a position in EXAS in Q4 2014 and held it in 6 quarters. The position peaked at $5.63M in Q4 2014. 527 funds tracked by Wall St. Rank hold EXAS as of Q4 2019.

  • Castleark Management reported no remaining Exact Sciences position as of Q4 2019 after selling out during the quarter.
  • Castleark Management sold 19,995 Exact Sciences shares in Q4 2019, an estimated $1.81M.
  • Castleark Management first reported a position in Exact Sciences in Q4 2014 and held it in 6 quarters.
  • Castleark Management's Exact Sciences position peaked at $5.63M in Q4 2014.
  • 527 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2019.

Based on Castleark Management's 13F filing for Q4 2019, filed 14 Feb 2020.